GUIDED THERAPEUTICS INC Quarterly Other Assets, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Guided Therapeutics Inc quarterly Other Assets, Current history and growth rate from Q4 2010 to Q2 2024.
  • Guided Therapeutics Inc Other Assets, Current for the quarter ending June 30, 2024 was $112K, a 23.1% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $112K +$21K +23.1% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $156K +$35K +28.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $163K +$26K +19% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $192K +$23K +13.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $91K +$32K +54.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $121K -$332K -73.3% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $137K -$240K -63.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $169K -$4K -2.31% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $59K -$2K -3.28% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $453K +$414K +1062% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $377K +$292K +344% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $173K +$63K +57.3% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $61K +$20K +48.8% Jun 30, 2021 10-Q 2021-08-18
Q1 2021 $39K +$3K +8.33% Mar 31, 2021 10-Q/A 2021-08-18
Q4 2020 $85K +$15K +21.4% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $110K +$4K +3.77% Sep 30, 2020 10-Q/A 2020-11-05
Q2 2020 $41K +$39K +1950% Jun 30, 2020 10-Q 2020-08-20
Q1 2020 $36K $0 0% Mar 31, 2020 10-Q 2020-07-07
Q4 2019 $70K +$1K +1.45% Dec 31, 2019 10-K 2021-04-07
Q3 2019 $106K -$2K -1.85% Sep 30, 2019 10-Q 2020-03-09
Q2 2019 $2K -$39K -95.1% Jun 30, 2019 10-Q 2020-02-11
Q1 2019 $36K -$54K -60% Mar 31, 2019 10-Q 2019-07-11
Q4 2018 $69K -$42K -37.8% Dec 31, 2018 10-K 2020-04-20
Q3 2018 $108K -$71K -39.7% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $41K Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $90K -$116K -56.3% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 $111K -$148K -57.1% Dec 31, 2017 10-K 2019-05-08
Q3 2017 $179K Sep 30, 2017 10-Q 2017-11-20
Q1 2017 $206K Mar 31, 2017 10-Q 2017-05-22
Q4 2016 $259K -$521K -66.8% Dec 31, 2016 10-K/A 2018-04-20
Q4 2015 $780K +$681K +688% Dec 31, 2015 10-K 2017-03-22
Q3 2015 $979K +$548K +127% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $28K +$15K +115% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $52K +$4K +8.33% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 $99K -$2K -1.98% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $431K +$246K +133% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $13K -$102K -88.7% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $48K -$199K -80.6% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $101K -$97K -49% Dec 31, 2013 10-K 2015-03-25
Q3 2013 $185K +$66K +55.5% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $115K +$76K +195% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $247K +$202K +449% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $198K +$144K +267% Dec 31, 2012 10-K 2014-03-26
Q3 2012 $119K Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $39K +$17K +77.3% Jun 30, 2012 10-Q/A 2012-08-24
Q1 2012 $45K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $54K +$24K +80% Dec 31, 2011 10-K 2013-03-27
Q2 2011 $22K Jun 30, 2011 10-Q 2011-11-14
Q4 2010 $30K Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.